To investigate the role and related cell signals of FNDC3B in GBM, we performed an in vitro study, including qRT-PCR, western blot analysis, proteome profiler phospho-kinase array, and MetaCore integrated pathway bioinformatics analysis. The gene discussed is FNDC3B; the disease is glioblastoma.